Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y013565 | — |
no adverse reactions were experienced; TE occurring on GARDASIL-9 and was administered after TE on 8/18/2025; Information has been received from an office manager, referred to a patient of unknown age and gender. The patient's medical history, concurrent condition, and concomitant therapy were not reported. On 18-Aug-2025, the patient vaccinated with improperly stored Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) injection (0.5 ml, frequency: total, lot #Y013565, expiration date: 01-Feb-2027, route, dose number unknown) for prophylaxis (Improper storage of product in use). No adverse reactions were experienced after the administered dose. The vaccine was exposure to temperature of 1.5 degree Celsius(C) for 2 hours and 24 minutes and 0.9 C for 5 hours and 14 minutes. The prior excursion was reported as on 08-Jul-2025, exposure to temperature of 8.3 C for 44 minutes. This is one of four cases received from the same reporter.